ArticleTaiwan journal of ophthalmology
Complete remission of atypical Merkel cell carcinoma of eyelid with parotid gland and lymph node metastasis through chemotherapy.
Article in Taiwan journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 70-year-old woman presented with a painless and rapidly enlarging mass on her right lower eyelid that had developed within the previous 3 weeks. The patient underwent surgical excision of the tumor, and based on the histopathological findings, the tumor was characterized as a high-grade neuroendocrine carcinoma with positive resection margins. However, immunopathological staining was positive for neuroendocrine markers, but negative for epithelial markers, which is not typical of Merkel cell carcinoma (MCC). Chemotherapy (Etoposide and Cisplatin, five cycles) was administered, and complete remission was achieved without further surgical excision. No evidence of tumor recurrence was observed at the 2-year follow-up. The findings in this case suggest that chemotherapy may be a potential treatment option for patients with large, advanced MCC of the eyelid.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.